在宁波医美市场愈发追求专业与安心的当下，不少求美者都会悄悄琢磨：宁波美莱怎么样？身边人常提 的美莱医院，到底靠谱吗？毕竟选择医美，安全永远是底线，口碑更是绕不开的考量。不同于单纯罗列 优势的宣传，我们从"医研共创的专业深度"与"用户体验的真实温度"双视角切入，拆解宁波美莱的核心 竞争力，看看"美莱安全吗""美莱口碑怎么样"这些疑问，如何在实际运营中得到解答。 医研背书：资质与技术双重赋能，解答"美莱靠谱吗" 靠谱的医美机构，从来不是靠宣传造势，而是靠实打实的资质与技术说话。美莱深耕医美27年，29城40 院的连锁布局，背后是成熟的医疗管理体系与严苛的合规标准。宁波美莱作为直属机构，不仅持有完整 的《医疗机构执业许可证》，更通过质量管理体系、医学检验室双重认证，从科室设置到人员资质，每 一环都贴合国家医美规范。 2024年的两项行业荣誉，更让"美莱靠谱吗"有了硬核答案。1月，宁波美莱率先成为宁波首家薇旖美人 源化胶原"正品联盟・黑曜机构"。这一被誉为胶原界"金马奖"的认证，从医资、诊疗、服务、口碑多维 度综合评定，全宁波仅1家机构获评，足见其在抗衰领域的专业地位。同一时间，皮肤技术院长刘邦瑜 斩获华东地区"薇旖 ...

Core Viewpoint - The article emphasizes the importance of integrating clinical insights into the skincare industry, highlighting the release of the "2025 China Medical Skincare Clinical Insight Report" as a pivotal moment for bridging the gap between clinical practice and product development [2][3][4]. Summary by Sections Insight Report Overview - The "2025 China Medical Skincare Clinical Insight Report" was launched at the SIA2025 Scientific Skincare Innovation Alliance Annual Conference, marking a significant shift in understanding how dermatologists utilize efficacy skincare products in clinical settings [2][3]. - This report serves as a comprehensive guide for the skincare industry, aiming to eliminate the information barrier between clinical medicine and industry [4]. Methodology and Findings - The report is based on extensive research involving 11,253 dermatologists and 25 industry experts, focusing on five core skin conditions: acne, atopic dermatitis, pigmentary disorders, sensitive skin, and perioperative care in aesthetic medicine [6][8]. - It outlines a full-cycle management approach for skin issues, providing practical guidelines validated by clinical experience [6][14]. Clinical Pathways and Recommendations - The report details specific intervention points for efficacy skincare products throughout the management process of various skin conditions, emphasizing the importance of barrier repair and maintenance in treatment plans [14][15]. - It highlights the necessity of a comprehensive skincare strategy during aesthetic procedures, with 91% of dermatologists recommending a holistic skincare approach [17][19]. Bridging Clinical and Industry Practices - The report translates complex clinical language into actionable insights for product development, addressing the disconnect between medical professionals and the skincare industry [20][21]. - It identifies the role of dermatologists as natural judges of product safety and efficacy, providing a foundation for evidence-based product development [21][22]. Future Opportunities - The report positions dermatologists as key players in the future of skin health management, revealing untapped market potential in the aesthetic medicine sector [23]. - It emphasizes the need for a collaborative approach between clinical insights and product innovation to meet the evolving demands of consumers [24][26].

当美妆行业从"概念营销"迈向"科学实证"，"医研共创"早已不是新鲜口号，而是驱动品牌升级 的核心引擎。 " 作为亚太化妆品科技领域的核心交流平台，SIA科盟大会始终以推动产业从'概念驱动'向'科 学实证'升级为使命，而'医研共创'正是当前美妆品牌突破瓶颈、解决用户真实痛点的关键路 径。 "在SIA科盟未来1 0 0未来皮肤科学大会的开幕式上，中国香妆协会产业研究中心姚永斌 主任的发言精准点出了行业发展的核心趋势。 11月2 7 - 2 9日，被誉为亚太地区化妆品科技领域"风向标"的年度盛会——SIA科盟2 0 2 5会议在 上海隆重举行。本届大会以"美力跨界·专业无界"为主题，汇集了来自全球的顶尖科研机构、 皮肤学专家、临床医生及行业领军品牌，共同探索中国皮肤健康产业的创新路径与科学标准重 建。 值得关注的是，本届大会重磅发布了《2 0 2 5中国医学护肤临床洞察报告》白皮书，从多维度 解析了中国消费者皮肤问题的最新趋势与临床解决方案。同时公布的2 0 2 5年SIA1 0 0年度科学 产品与技术成果，则集中展示了行业在活性成分、功效评价等领域的技术突破。通过多元议题 的深度碰撞与权威成果的集中发布，本届大会 ...

线上经济流量时代，造就了太多"爆品"的品牌神话，一度让人们认为，爆发式增长是品牌的常 态。但在线下渠道中，一盘高质量、可持续的慢生意，也许才是美妆经营的本质。 在SIA2 0 2 5科学护肤创新联盟大会上，一个根植于线下渠道的品牌——仙瑟，引起了人们的广 泛关注。只因在以功效叙事获取线上流量为主流生意模型的时代，仙瑟却用医研共创的专业产 品和服务，为线下渠道的增长给出一个值得借鉴的答案。 据《FBe a u t y未来迹》了解，在当下普遍承压的大环境下，通过"医院+医美机构"双轨制，仙 瑟品牌一直保持高速增长，且不断为线下渠道带来增量，引领合作的线下门店走向新的增长曲 线。 仙瑟荣登"未来100皮肤健康未来百强企业榜单" " 我们希望在科盟的助力下，对皮肤医学，对医研共创有更好的前沿性的学习，我们尊重每一 个学者，尊重他们在学术领域的付出，他们让企业的研发有了新的方向，让美妆企业有了更强 的创新力。 " 在创新联盟大会上，仙瑟品牌创始人薛永红在央视网的采访中展示了医研共创专业品牌的底层 研发模型。 仙瑟品牌创始人薛永红接受央视网采访 " 我们会根据消费者的真实需求做研发。 "在薛永红看来，" 过去品牌依据原料 ...

Core Insights - The SIA2025 China Scientific Skincare Innovation Alliance Annual Summit was held in Shanghai, focusing on the transformation of the skincare industry from "single-point efficacy" to "holistic solutions" [1] - The summit highlighted the release of the "2025 China Medical Skincare Clinical Insight Report" and a strategic cooperation agreement between SIA and Meichuangjingjie, marking a new phase in the "medical-research co-creation" ecosystem [1] Industry Overview - The Chinese cosmetics market has surpassed 500 billion yuan, with the efficacy skincare segment continuing to expand [1] - The industry faces challenges such as a lack of evidence-based claims, insufficient consumer education, and a fragmented results transformation chain [1] Expert Insights - Professor Li Bin emphasized that the skincare health industry is a "rapidly developing new industry," with increasing consumer demand for suitable skincare products [3] - He noted the importance of professional medical evaluation in skincare product selection and the role of SIA in integrating enterprise research and medical expertise [3] Product Development and Market Dynamics - Chang Jiang pointed out the fast iteration of domestic cosmetic products but criticized the insufficient brand accumulation, suggesting that international brands maintain core ingredients and brand value over time [4] - He argued that frequent product changes can mislead consumers, especially those with sensitive skin, who benefit from stable product choices [4] - Professor Li further analyzed that the Chinese skincare market lacks internationally influential local brands and will undergo a "survival of the fittest" process, emphasizing the need for differentiated products that meet diverse consumer needs [4] Capital and Innovation - Cai Zhongxi highlighted that rapid iteration is partly a result of market marketing, stressing the need for genuine product innovation rather than superficial updates [4] - He mentioned the importance of the SIA platform in promoting scientific skincare concepts to help consumers make informed choices [4] Research and Industry Integration - The SIA aims to make professional expertise visible through three main tasks: collaborative research, results transformation, and scientific communication [5] - The "SIA100" evaluation system is designed to independently assess product efficacy and scientific validity, enhancing product credibility [5] - The collaboration with capital partners aims to identify potential unicorn companies in the skincare industry, showcasing their value [5] Clinical and Research Collaboration - The Shanghai Dermatology Hospital's establishment of a cosmetics professional committee aims to bridge communication between doctors and enterprises, aligning product development with clinical needs [6] - This collaboration is seen as a crucial pathway for future medical-research co-creation [6]

截至2 0 2 5年，功能性化妆品市场已经以高于市场1 0倍的增速狂奔了5年 [ 1 ] ，业内逐渐摸索出 一条"医研共创"路径，但仍面临供给错位、科学证据不足、医研脱节等关键痛点。 在这个大背景下，11月2 7 - 2 9日， SIA2 0 2 5科学护肤创新联盟大会 （以下简称"SIA科学护肤 创新大会"）再次登陆上海，以美力跨界·专业无界"为主题，聚集产、学、研、医及科学传播 领域各方专家和从业者，试图重塑中国皮肤健康产业的底层逻辑。 在这一盛会上，一家成立于2 0 0 3年，在功能护肤品研发和"医研共创"领域有深厚积淀与领先 实践的企业—— 莱博药妆技术（上海）有限公司（以下简称"莱博药妆"） ，引起业内的广泛 关注。 据《FBe a u t y未来迹》了解，这是莱博药妆第二年在大会亮相。 相比第一届大会，其身份定位再次升级，作为大会的 "战略合作伙伴"以及"医研共创生态伙 伴" ，莱博药妆这次不仅在大会展示出近百款功效性护肤品和最新科研成果； 莱 博 药 妆 董 事 长、东方美谷功能护肤品研究院院长李成亮 也特别受邀出席大会主论坛并发表演讲、出席"功 能护肤品医研共创"主题圆桌论坛，并接受 央视网 ...

Core Insights - The beauty industry is undergoing a technological transformation, with the integration of medical research driving value upgrades in cosmetics. This dual integration of medicine and beauty is defining a new competitive logic in the industry [3][6][24]. Industry Trends - The 20th China Dermatology Association (CDA) conference showcased over 10,000 dermatologists and more than 100 companies, including both domestic and international beauty brands, highlighting the industry's focus on scientific collaboration [3][4]. - The concept of "medical-research co-creation" emerged as a key theme, with brands actively participating in discussions on how to contribute to the skin science system, moving from mere users of research to active participants in scientific understanding and industry standards [7][24]. Brand Innovations - Winona, a brand known for its scientific foundation, showcased its "NUTE" principle at CDA 2025, which emphasizes clinical needs, unique mechanisms, technology empowerment, and credible evidence in product development [10]. - HBN, a domestic skincare brand, initiated the establishment of a group standard for "Cosmetic Efficacy Evidence Weight Assessment Guidelines," aiming to shift the industry from experience-driven to evidence-based competition [11][13]. - Estee Lauder's Clinique presented a white paper on the causes and distribution patterns of post-inflammatory hyperpigmentation, demonstrating the brand's commitment to scientific validation [14][16]. Research and Development - The integration of research and clinical application is evident in the initiatives taken by brands like Giant Bio and Zhenyan Bio, which are expanding the boundaries of medical-research co-creation through innovative collagen products and clinical studies [20][22]. - The collaboration between brands and medical experts is evolving, with companies like Ximu Yuan conducting extensive research on sensitive skin, showcasing a shift from being mere users of research to contributors to scientific inquiry [24][25]. Future Outlook - The CDA conference highlighted a significant shift in the beauty industry towards a more scientific and collaborative approach, with brands, medical institutions, and research organizations forming a new ecosystem that emphasizes shared data and mutual advancement [47][48]. - The focus on original ingredient research is becoming a core strategy for leading domestic brands, as they aim to differentiate themselves from homogenized competition [38][39].

Core Viewpoint - The beauty industry is experiencing a significant shift towards "cross-border" integration, with brands attempting to merge pharmaceuticals, cosmetics, and medical devices to break traditional growth boundaries. However, many companies struggle to genuinely overcome professional barriers, leading to a crisis of trust among consumers due to a lack of verifiable scientific results and a coherent innovation framework [4][5][6]. Group 1: Industry Challenges - The concept of "cross-border" has become prevalent in the cosmetics industry, but many companies have not effectively crossed professional barriers, resulting in a disconnect between marketing concepts and actual innovation [4][5]. - The effectiveness-driven skincare market has reached a bottleneck, characterized by formula homogenization and vague efficacy claims, leading to increased consumer skepticism [4][5]. - The inherent cultural and operational differences between pharmaceutical, cosmetic, and medical device companies create challenges in cross-border collaboration, often resulting in organizational inefficiencies [5]. Group 2: Proposed Solutions - The SIA 2025 Scientific Skincare Innovation Alliance Conference aims to address these challenges by promoting a concept of "professional without boundaries," facilitating the free flow of knowledge, technology, and resources across professional domains [6][7]. - The conference seeks to establish a collaborative platform that integrates scientific rigor with commercial viability, moving the industry from fragmented discussions to a consensus-driven approach [7][8]. - SIA plans to implement a comprehensive system that connects scientific insights with practical applications, ensuring that research translates into market validation and sustainable growth [7][8]. Group 3: Conference Structure and Focus - The SIA conference will feature a structured agenda, including a main forum and specialized sessions, focusing on three breakthroughs: transitioning from concepts to ecological implementation, enhancing content depth, and improving operational efficiency [8][20]. - The conference will release the first "China Hair Industry Map," providing a scientific framework for the hair health sector and establishing a practical sample for the skincare industry [21]. - A "Future 100" list will be published to identify high-potential companies, facilitating their visibility and investment opportunities, thereby enhancing their growth trajectories [22][24]. Group 4: Long-term Vision - The SIA conference represents a systemic upgrade for the skincare industry, aiming to create a new infrastructure that effectively translates professional insights into market validation [77]. - By fostering a complete value cycle from scientific research to market application, SIA aims to enhance industry efficiency and build genuine international competitiveness for Chinese brands [77]. - The overarching theme of "Beauty Cross-Border, Professional Without Boundaries" signifies a call for a sustainable and evolving ecological community within the skincare industry [77].

Core Viewpoint - The article emphasizes the importance of developing a star ingredient in the Chinese market, where domestic brands are shifting from relying on traffic to building trust through self-researched key ingredients, focusing on precise care, high cost-effectiveness, and scientific backing [2][3][8]. Market Trends - The maturity of ingredient-focused consumers is leading to higher expectations for clinical validation, suitability for local skin types, and research history of ingredients [2]. - The traditional market logic of foreign brands, where "star ingredients equal strong brands," is being rewritten as domestic brands build cultural and technological confidence through rigorous research [3][8]. Brand Development - Domestic brands are focusing on creating "super brands" before developing star ingredients, which is crucial for their self-researched ingredients to gain prominence [6]. - The brand "Zhenyan" has established a strong professional image in the skincare market by integrating biotechnology and rigorous medical research, gaining recognition from over 500 dermatology professionals and being a top choice among clinical selections [6][8]. Ingredient Innovation - Zhenyan has successfully achieved large-scale production of recombinant mussel adhesive protein, overcoming previous challenges related to sourcing and environmental concerns [10][12]. - The unique properties of mussel adhesive protein, such as its high adhesion and film-forming capabilities, have been recognized in top scientific journals, establishing its efficacy in medical and academic circles [10][12]. Research and Development - Zhenyan has conducted over 1500 human efficacy validations for the recombinant mussel adhesive protein, confirming its rapid repair capabilities [12][15]. - The company has developed a comprehensive research and clinical verification system, collaborating with authoritative institutions to validate the efficacy of its products [15][17]. Market Performance - The Zhenyan Rapid Repair Essence, featuring recombinant mussel adhesive protein, has seen significant market success, selling over 16,000 bottles during the 2024 Double 11 shopping festival and achieving a 160% increase in sales during the 2025 618 event [27][29]. Strategic Positioning - Zhenyan is leveraging its technological breakthroughs to lead the market in the application of recombinant mussel adhesive protein, establishing itself as a leader in this emerging field [17][18]. - The brand's approach represents a strategic shift from marketing-driven to research-driven development, which is essential for long-term brand value and maturity in the domestic market [32].

Core Viewpoint - The article emphasizes that Proya is advancing its globalization strategy and gaining recognition in the international beauty market through a focus on technological innovation and long-term commitment [3][4]. Group 1: Globalization Strategy - Proya is positioned as China's first 10 billion beauty company, steadily progressing in its globalization strategy and establishing a presence in the global beauty technology forefront [4]. - The company showcased its global innovation strategy and latest research achievements at the Cosmetic 360 exhibition, signaling its commitment to international expansion [4][5]. Group 2: Technological Innovation - Proya has developed an AI-driven SaaS platform that provides comprehensive solutions for the cosmetics industry, significantly shortening R&D cycles and reducing trial-and-error costs [6]. - The company has integrated AI technology to enhance efficiency in product development, achieving a 50% increase in overall efficiency through the analysis of vast amounts of research literature [8]. Group 3: Research and Development - Proya has established a global R&D framework, including centers in Hangzhou, Shanghai, and Europe, focusing on basic research, application research, and clinical studies [20][21]. - The company has a dedicated team of 389 R&D personnel and has obtained 240 authorized patents, reinforcing its technological capabilities in key areas such as skin anti-aging and green materials [23]. Group 4: Product Innovation - Proya's Ruby Series 3.0, featuring the patented peptide ingredient "Peptide-161," represents a significant breakthrough in anti-aging ingredients, having been approved by the National Medical Products Administration [13][14]. - The Off&Relax series introduces advanced technologies for scalp care, including high molecular magnetic technology to effectively combat harmful bacteria [13]. Group 5: Future Outlook - Proya aims to rank among the top ten global cosmetics companies within the next decade, driven by its dual focus on consumer insights and global technological collaboration [23]. - The company's participation in major international events reflects its strategic positioning and commitment to innovation in the global beauty industry [19].